Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.39 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | C1S | P09871 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | AGXT | P21549 | 2/20 | 0.37 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8765439 | 0.97 | ALDH1A1 (0.44) | ALDH1A1MAPK1TAAR1MTNR1AMTNR1B | |
| SCHEMBL9160410 | 0.95 | ALDH1A1 (0.42) | ALDH1A1MAPK1TAAR1MTNR1AMTNR1B | |
| SCHEMBL4890429 | 0.93 | ALDH1A1 (0.46) | ALDH1A1MAPK1MTNR1AMTNR1BTDP1 | |
| SCHEMBL29634606 | 0.93 | ALDH1A1 (0.46) | ALDH1A1MAPK1MTNR1AMTNR1BTDP1 | |
| SCHEMBL9321120 | 0.93 | ALDH1A1 (0.46) | ALDH1A1MAPK1MTNR1AMTNR1BTDP1 | |
| SCHEMBL14235312 | 0.91 | ALDH1A1 (0.43) | ALDH1A1MAPK1MTNR1AMTNR1BTDP1 | |
| SCHEMBL2450999 | 0.91 | ALDH1A1 (0.48) | ALDH1A1MAPK1MTNR1AMTNR1BTDP1 | |
| SCHEMBL30803098 | 0.91 | ALDH1A1 (0.43) | ALDH1A1MAPK1MTNR1AMTNR1BTDP1 | |
| SCHEMBL15553143 | 0.91 | ALDH1A1 (0.48) | ALDH1A1MAPK1MTNR1AMTNR1BTDP1 | |
| SCHEMBL12156936 | 0.89 | ALDH1A1 (0.38) | ALDH1A1MAPK1TAAR1MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114341104-B | Dopant and conductive composition, and method for producing same | 国立大学法人东京大学 | 2024-03-15 | — | — | CN | disclosed |
| CN-114341104-A | Dopant and conductive composition and method for producing the same | 国立大学法人东京大学 | 2022-04-12 | — | — | CN | disclosed |
| US-8796490-B2 | Method of producing a triarylamine compound | FUJIFILM CORPORATION (JP) | 2014-08-05 | — | — | US | disclosed |
| US-8796490-B2 | Method of producing a triarylamine compound | FUJIFILM CORPORATION (JP) | 2014-08-05 | — | — | US | disclosed |
| US-20110269994-A1 | METHOD OF PRODUCING A TRIARYLAMINE COMPOUND | FUJIFILM CORPORATION (JP) | 2011-11-03 | — | — | US | disclosed |
| US-20110269994-A1 | METHOD OF PRODUCING A TRIARYLAMINE COMPOUND | FUJIFILM CORPORATION (JP) | 2011-11-03 | — | — | US | disclosed |
| US-20100068635-A1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, AND IMAGE FORMING METHOD, IMAGE FORMING APPARATUS AND PROCESS CARTRIDGE USING THE ELECTROPHOTOGRAPHIC PHOTORECEPTOR | RICOH COMPANY, LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| JP-2005306738-A | TETRAAMINE COMPOUND, TRIS(3-BROMOPHENYL)AMINE AND THEIR MANUFACTURING METHODS | RICOH CO LTD | 2005-11-04 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269994-A1 | METHOD OF PRODUCING A TRIARYLAMINE COMPOUND | AADAC, PNMT, INMT | ALDH1A1 2545/4885MAPK1 3727/4885TAAR1 46/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.